These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9027866

  • 1. Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencyclidine and dizocilpine maleate.
    Blacker D, Broberger C, Ogren SO, Hökfelt T.
    Neuroscience; 1997 Feb; 76(4):1057-67. PubMed ID: 9027866
    [Abstract] [Full Text] [Related]

  • 2. Locomotor activity induced by the non-competitive N-methyl-D-aspartate antagonist, MK-801: role of nucleus accumbens efferent pathways.
    De Leonibus E, Mele A, Oliverio A, Pert A.
    Neuroscience; 2001 Feb; 104(1):105-16. PubMed ID: 11311535
    [Abstract] [Full Text] [Related]

  • 3. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM, Steele TD, Sharpe LG.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [Abstract] [Full Text] [Related]

  • 4. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D, Zhang J, Engel JA, Svensson L.
    Behav Brain Res; 2005 Apr 15; 159(1):95-103. PubMed ID: 15795002
    [Abstract] [Full Text] [Related]

  • 5. Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.
    Kusljic S, Brosda J, Norman TR, van den Buuse M.
    Brain Res; 2005 Jul 12; 1049(2):217-26. PubMed ID: 15953591
    [Abstract] [Full Text] [Related]

  • 6. Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801.
    Jacobs PS, Taylor BM, Bardgett ME.
    Brain Res Dev Brain Res; 2000 Jul 30; 122(1):91-5. PubMed ID: 10915909
    [Abstract] [Full Text] [Related]

  • 7. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH, Barton CL, Jay M, Blurton P, Burkamp F, Clarkson R, Bristow LJ.
    Neuropharmacology; 2000 Sep 30; 39(12):2318-28. PubMed ID: 10974315
    [Abstract] [Full Text] [Related]

  • 8. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists.
    Chartoff EH, Heusner CL, Palmiter RD.
    Neuropsychopharmacology; 2005 Jul 30; 30(7):1324-33. PubMed ID: 15688082
    [Abstract] [Full Text] [Related]

  • 9. A further study on asymmetric cross-sensitization between MK-801 and phencyclidine-induced ambulatory activity.
    Xu X, Domino EF.
    Pharmacol Biochem Behav; 1999 Jul 30; 63(3):413-6. PubMed ID: 10418782
    [Abstract] [Full Text] [Related]

  • 10. Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats.
    Millan MJ, Audinot V, Honoré P, Bervoets K, Veiga S, Brocco M.
    Eur J Pharmacol; 2000 Jan 24; 388(1):37-47. PubMed ID: 10657545
    [Abstract] [Full Text] [Related]

  • 11. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity.
    Mele A, Thomas DN, Pert A.
    Neuroscience; 1998 Jan 24; 82(1):43-58. PubMed ID: 9483502
    [Abstract] [Full Text] [Related]

  • 12. Phencyclidine and dizocilpine modulate dopamine release from rat nucleus accumbens via sigma receptors.
    Ault DT, Werling LL.
    Eur J Pharmacol; 1999 Dec 15; 386(2-3):145-53. PubMed ID: 10618464
    [Abstract] [Full Text] [Related]

  • 13. Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.
    Ogren SO, Goldstein M.
    Neuropsychopharmacology; 1994 Nov 15; 11(3):167-77. PubMed ID: 7865098
    [Abstract] [Full Text] [Related]

  • 14. Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex.
    Etou K, Kuroki T, Kawahara T, Yonezawa Y, Tashiro N, Uchimura H.
    Pharmacol Biochem Behav; 1998 Dec 15; 61(4):427-34. PubMed ID: 9802838
    [Abstract] [Full Text] [Related]

  • 15. Enhanced locomotor stimulation by NMDA receptor antagonists in alcohol-sensitive ANT rats.
    Vekovischeva OY, Haapalinna A, Näkki R, Sarviharju M, Honkanen A, Heikkilä J, Korpi ER.
    Pharmacol Biochem Behav; 2000 Dec 15; 67(4):793-9. PubMed ID: 11166070
    [Abstract] [Full Text] [Related]

  • 16. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.
    Carlsson M, Svensson A.
    Life Sci; 1990 Dec 15; 47(19):1729-36. PubMed ID: 2147454
    [Abstract] [Full Text] [Related]

  • 17. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ, Hutson PH, Thorn L, Tricklebank MD.
    Br J Pharmacol; 1993 Apr 15; 108(4):1156-63. PubMed ID: 8485625
    [Abstract] [Full Text] [Related]

  • 18. Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: possible relationship to ingestive behavior.
    Qian M, Johnson AE, Källström L, Carrer H, Södersten P.
    Neuroscience; 1997 Apr 15; 77(4):1077-89. PubMed ID: 9130789
    [Abstract] [Full Text] [Related]

  • 19. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
    Kuroki T, Tatebayashi Y, Ide K, Yonezawa Y, Tsutsumi T, Matsumoto T, Hirano M, Uchimura H.
    Neuropeptides; 1992 Mar 15; 21(3):167-73. PubMed ID: 1385857
    [Abstract] [Full Text] [Related]

  • 20. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
    Sun X, Larson AA.
    Neuroscience; 1993 Jun 15; 54(3):773-9. PubMed ID: 8101361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.